RH

Regencell Bioscience Holdings

RGC
NASDAQHealth Care
$18.83
USD
-0.86(-4.37%)
At close: Jun 12, 20:00 UTC

Open

$19.04

Prev. Close

$19.04

High

$19.04

Low

$18.90

Market Snapshot

Market Cap

$9.31B

EPS

-1.44

Employees

10

About

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 10 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Recently from Cashu